Eyenovia Inc (NASDAQ: EYEN) kicked off on Monday, down -17.38% from the previous trading day, before settling in for the closing price of $0.11. Over the past 52 weeks, EYEN has traded in a range of $0.08-$2.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 100.00%. While this was happening, its average annual earnings per share was recorded 12.40%. With a float of $77.72 million, this company’s outstanding shares have now reached $86.44 million.
Let’s determine the extent of company efficiency that accounts for 57 employees. In terms of profitability, gross margin is -4716.41%, operating margin of -109178.31%, and the pretax margin is -118845.16%.
Eyenovia Inc (EYEN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Eyenovia Inc is 10.09%, while institutional ownership is 15.41%. The most recent insider transaction that took place on Aug 28 ’24, was worth 14,077. In this transaction Chief Executive Officer of this company bought 27,071 shares at a rate of $0.52, taking the stock ownership to the 109,998 shares. Before that another transaction happened on Aug 26 ’24, when Company’s Chief Executive Officer bought 50,000 for $0.57, making the entire transaction worth $28,500. This insider now owns 82,927 shares in total.
Eyenovia Inc (EYEN) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.16 earnings per share (EPS), higher than consensus estimate (set at -0.17) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.40% per share during the next fiscal year.
Eyenovia Inc (NASDAQ: EYEN) Trading Performance Indicators
Take a look at Eyenovia Inc’s (EYEN) current performance indicators. Last quarter, stock had a quick ratio of 0.53. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 256.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.73, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.31 in one year’s time.
Technical Analysis of Eyenovia Inc (EYEN)
Looking closely at Eyenovia Inc (NASDAQ: EYEN), its last 5-days average volume was 26.12 million, which is a jump from its year-to-date volume of 2.09 million. As of the previous 9 days, the stock’s Stochastic %D was 4.46%. Additionally, its Average True Range was 0.05.
During the past 100 days, Eyenovia Inc’s (EYEN) raw stochastic average was set at 0.67%, which indicates a significant decrease from 2.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 505.89% in the past 14 days, which was higher than the 230.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4373, while its 200-day Moving Average is $0.8411. However, in the short run, Eyenovia Inc’s stock first resistance to watch stands at $0.0985. Second resistance stands at $0.1082. The third major resistance level sits at $0.1179. If the price goes on to break the first support level at $0.0791, it is likely to go to the next support level at $0.0694. Now, if the price goes above the second support level, the third support stands at $0.0597.
Eyenovia Inc (NASDAQ: EYEN) Key Stats
The company with the Market Capitalisation of 7.68 million has total of 86,442K Shares Outstanding. Its annual sales at the moment are 4 K in contrast with the sum of -27,260 K annual income. Company’s last quarter sales were recorded 20 K and last quarter income was -11,050 K.
